Influence of Fuzheng Huayu Tablet on mental state and social function of patients with post-hepatitis B liver cirrhosis

Chinese Journal of Integrative Medicine

Volumn 18, Issue 6, 2012, Pages 466-472

  Deng, Xin ^a   Liang, Jian ^a   Wu, Fa Sheng ^a   Li, Yan Bo ^a   Zhang, Ya Ping ^a   Tang, Yan Fang ^a  

^a RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Fuzheng Huayu Tablet; Mental state; Post hepatitis B liver cirrhosis; Social activity

Indexed keywords

ALBUMIN; BILIRUBIN; CHINESE DRUG; COLLAGEN TYPE 4; FUZHENG HUAYU; PROTHROMBIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PROTHROMBIN TIME; SCORING SYSTEM; SELF-RATING ANXIETY SCALE; SELF-RATING DEPRESSION SCALE; SOCIAL BEHAVIOR; SOCIAL DEFICIT SCREENING SCALE; SOCIAL STATUS; SPLEEN; TABLET; TREATMENT DURATION;

BLOOD COAGULATION; DRUGS, CHINESE HERBAL; HEPATITIS B; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; PATIENT DROPOUTS; SOCIAL BEHAVIOR; TABLETS;

EID: 84867317343     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-012-1112-0     Document Type: Article

References (26)

1. Lu ZY, Zhong NS. Internal medicine science (7th ed). Beijing:People's Medical Publishing House; 2008: 453-454.
2. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242-249.
3. Li WY, Jiang YF, Jin QL Zhang H, Feng XW, Niu JQ. Immunologic characterization of posthepatitis cirrhosis caused by HBV and HCV infection. J Biomed Biotechnol 2010;14:138-145.
4. Anna S, Brian J. Chronic hepatitis B. Hepatology 2007;45:507-538.
5. Jordi B, Morris S, Josep M. Clinical management of hepatocellular carcinoma.conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421-430.
6. Yang HZ, Wang FL, Wang YZ, Shen WS, Xu GL, Yang YW, et al. The clinical study on chronic hepatitis B treated by the four-step therapeutics of traditional Chinese medicine. J Chin Med Mat (Chin) 2006;29:748-752.
7. Shi WQ, Ru QJ, Cai GY. Effect of umbilical sticking therapy with Qi Tou Xiao Gu plaster in treating liver cirrhosis patients with portal hypertension. Chin J Integr Tradit West Med (Chin) 2008;28:642-647.
8. Den X, Liang J, Wu FS, Li YB, Tang YF. Influence of traditional Chinese medicine therapy on quality of life of patients with posthepatitic cirrhosis. Lishizhen Med Mater Med Res (Chin) 2010;21:3314-3316.
9. Liang J, Den X, Yu L, Wu FS, Li X, An YH. Study on the establishment of the evaluation index system of Chinese medicine treatment of hepatitis cirrhosis. Liaoning J Tradit Chin Med (Chin) 2009;6:2017-2019.
10. Digestive System Disease Committee of Chinese Association of integrative Medicine. Cirrhosis of combining traditional Chinese and western medicine treatment scheme (draft). Chin J Integr Tradit West Med (Chin) 2004;24:869-871.
11. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010;53:397-417.
12. Santini MT, Rainaldi G, Indovina PL. Multicelluar tumour spheroids in radiation biology. Int J Radiat Biol 1999;75:787-789.
13. Zhang MY. Manual of rating scales for psychiatry. Changsha: Hunan Science and Technology Press; 1993: 162-164.
14. Tan CY, Liu P. Theoretical origin of pathogenesis on accumulation due to deficiency of liver cirrhosis and clinical significance. Acta Univ Tradit Med Sin Pharmacol Shanghai (Chin) 2010;24(4):25-28.
15. Zhang Q, Liu P, Zhang HW, Wang L, Dou GL, Chen HF, et al. Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis. Chin J Integr Tradit West Med (Chin) 2006;26:694-697.
16. Yuan Z. Cl inicalapplicative characteristics of biopsychosocial medical mode. Chin J Clin Rehabilit (Chin) 2005;9:252-253.
17. Kim SH, Oh EG, Lee WH. Symptom exper ience, psychological distress, and quality of life in Korean patients with liver cirrhosis: a cross-sectional survey. Int J Nurs Stud 2006;43:1047-1056.
18. Tang JS, Xu CM, Zhai J, Zhao GF, Li CQ, Liang YR. A study on the relationship of social disability to subjective support and the degree of condition in patients with anxiety. Chin J Clin Rehabilit (Chin) 2003;7:2568-2569.
19. Zandi M, Adib-Hajbagheri M, Memarian R, Nejhad AK, Alavian SM. Effects of a self-care program on quality of life of cirrhotic patients referring to Tehran Hepatitis Center. Health Qual Life Outcomes 2005;18;3:35.
20. Luk JM, Wang X, Liu P, Wong KF, Chan KL, Tong Y, et al. Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer:from laboratory discovery to clinical evaluation. Liver Int 2007;27:879-890.
21. Li YM, Yang HZ, Guan WB, Ke QS, Dai M, Xie HP, et al. Therapeutic effect of traditional Chinese medicine on coagulation disorder and accompanying intractable jaundice in hepatitis B virus-related liver cirrhosis patients. World J Gastroenterol 2008;14:6060-6063.
22. Huang J, Huang H, Jiao Y, Ai G, Huang T, Li L, et al. Effect of anluohuaxian tablet combined with gamma-IFN on schistosomal liver fibrosis. J Huazhong Univ Sci Technol Med Sci (Chin) 2009;29:53-61.
23. Tong GD, Zhou DQ, He JS, Zhang L, Chen ZF, Xiao CL, et al. Clinical research on navel application of Shehuang Paste combined with Chinese herbal colon dialysis in treatment of refractory cirrhotic ascites complicated with azotemia. World J Gastroenterol 2006;12:7798-7804.
24. Liang J, Qin LK, Den X, Wu FS, Li X, An YH. Systematic review of therapeutic effects of traditional Chinese medicine on posthepatitic cirrhosis at early stage. Acta Univ Tradit Med Sin Pharmacol Shanghai (Chin) 2009;23:20-23.
25. Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, et al. Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther 2009;30:469-476.
26. Jin S, Yan L, Li B, Wen T, Zhao J, Zeng Y, et al. Quality of life and psychologic distress of recipients after adult livingdonor liver transplantation (LDLT)-A study from mainland China. Transplant Proc 2010;42:2611-2616.